PF-04447943
- Generic Name
- PF-04447943
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H25N7O2
- CAS Number
- 1082744-20-4
- Unique Ingredient Identifier
- 7N969W8Y4O
- Background
PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
- Associated Conditions
- -
- Associated Therapies
- -
A Study To Evaluate The Effect Of PF-04447943 On Qtc Interval In Healthy Adult Subjects
- First Posted Date
- 2016-05-30
- Last Posted Date
- 2018-12-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 44
- Registration Number
- NCT02785770
- Locations
- ๐บ๐ธ
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease
- First Posted Date
- 2009-10-02
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 15
- Registration Number
- NCT00988598
- Locations
- ๐บ๐ธ
MD Clinical, Hallandale Beach, Florida, United States
๐บ๐ธGlendale Adventist Medical Center, Glendale, California, United States
๐บ๐ธUniversity of Florida - Center for Clinical Trials Research, Gainesville, Florida, United States
Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects.
- First Posted Date
- 2009-08-17
- Last Posted Date
- 2009-12-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 17
- Registration Number
- NCT00959803
- Locations
- ๐บ๐ธ
Pfizer Investigational Site, Glendale, California, United States
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
- First Posted Date
- 2009-06-30
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 191
- Registration Number
- NCT00930059
- Locations
- ๐บ๐ธ
Lake Charles Clinical Trials, LLC, Lake Charles, Louisiana, United States
๐บ๐ธNeurocare, Inc., Newton, Massachusetts, United States
๐จ๐ฆMedical Arts Health Research Group, Kelowna, British Columbia, Canada
A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants
- First Posted Date
- 2009-04-22
- Last Posted Date
- 2009-07-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10
- Registration Number
- NCT00886093
- Locations
- ๐บ๐ธ
Pfizer Investigational Site, New Haven, Connecticut, United States
A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.
- First Posted Date
- 2009-01-29
- Last Posted Date
- 2009-06-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 32
- Registration Number
- NCT00832052
- Locations
- ๐บ๐ธ
Pfizer Investigational Site, Gainesville, Florida, United States
A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2009-02-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10
- Registration Number
- NCT00736528
- Locations
- ๐บ๐ธ
Pfizer Investigational Site, Gainesville, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.